Planning

Licensed Bulk Medicines

VELINDRE NHS TRUST, NHS WALES SHARED SERVICES PARTNERSHIP — PROCUREMENT SERVICES (ON BEHALF OF ALL WALES LHB'S AND TRUSTS)

This public procurement record has 1 release in its history.

Planning

09 Jun 2023 at 09:24

Planning Notice
Summary of the contracting process

The Velindre NHS Trust, NHS Wales Shared Services Partnership is planning a tender for purchasing Licensed Bulk Medicines with an estimated value of £42,317,736.61 per annum. The products will be available in licensed bulk containers over a 5-year timeframe. The tender falls under the pharmaceutical products classification and is open for suppliers who can meet the specified presentation requirements. The procurement stage is currently in the planning phase, and interested parties can expect future notices by January 1, 2025.

This tender opportunity presents a lucrative chance for pharmaceutical suppliers to engage in supply contracts with the NHS in Wales. Businesses specializing in pharmaceutical products, particularly those capable of providing licensed bulk presentations, are well-suited to compete in this tender. The Velindre NHS Trust acts as the purchasing authority, and the procurement process is governed by public law, focusing on Health-related goods procurement in the UK.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Licensed Bulk Medicines

Notice Description

We are interested in buying the following list of products, in licensed bulk containers of up to the sizes noted below, to be available within a 5 year timeframe. We consider the availability in licensed bulk presentation to be a significant market advantage and are willing to consider entering contracts for supply with suppliers who can meet this presentation requirement for these products. Estimated value in the Wales market of this list is PS42,317,736.61 p/a at current prices. The list is not exhaustive, and we are willing to consider other generic and biosimilar products if licensed bulk presentation can be offered. Drug,Strength,Proposed Vial Size ARSENIC TRIOXIDE,1mg/mL, AZACITIDINE,25mg/mL,500mL BEVACIZUMAB,25mg/mL,100mL - 250mL BORTEZOMIB,2.5mg/mL,50mL CALCIUM FOLINATE,10mg/mL,1000mL CARBOPLATIN,10mg/mL,1000mL CETUXIMAB,5mg/mL,250m - 500mL CISPLATIN,1mg/mL,500mL - 1000mL CYCLOPHOSPHAMIDE,20mg/mL,500mL CYTARABINE,100mg/mL or 20mg/mL,250mL DARATUMUMAB,20mg/mL,100mL - 250mL DOCETAXEL,20mg/mL,250mL - 500mL DOXORUBICIN,2mg/mL,1000mL EPIRUBICIN,2mg/mL,1000mL ETOPOSIDE,20mg/mL,500mL FLUCLOXACILLIN,,3000mL FLUOROURACIL,50mg/mL or 25mg /mL,250-500mL INFLIXIMAB,10mg/mL,500mL - 1000mL IRINOTECAN,20mg/mL,1000mL NIVOLUMAB,10mg/mL,250mL OXALIPLATIN,5mg/mL,500mL-1000mL PACLITAXEL,6mg/mL,1000mL PEMBROLIZUMAB,25mg/mL,100mL - 250mL PEMETREXED,25mg/mL,100mL - 250mL PIPERACILLIN & TAZOBACTAM,,3000mL RITUXIMAB,10mg/mL,500mL TOCILIZUMAB,20mg/mL,250mL TRASTUZUMAB EMTANSINE,20mg/mL,100mL - 250mL VEDOLIZUMAB,60mg/mL,250mL VITLIPID N INFANT,N/A,250mL Please inform us via the contact information above if you are able to provide these products.

Lot Information

Lot 1

We are interested in buying the following list of products, in licensed bulk containers of up to the sizes noted below, to be available within a 5 year timeframe. We consider the availability in licensed bulk presentation to be a significant market advantage and are willing to consider entering contracts for supply with suppliers who can meet this presentation requirement for these products. Estimated value in the Wales market of this list is PS42,317,736.61 p/a at current prices. The list is not exhaustive, and we are willing to consider other generic and biosimilar products if licensed bulk presentation can be offered. Drug,Strength,Proposed Vial Size ARSENIC TRIOXIDE,1mg/mL, AZACITIDINE,25mg/mL,500mL BEVACIZUMAB,25mg/mL,100mL - 250mL BORTEZOMIB,2.5mg/mL,50mL CALCIUM FOLINATE,10mg/mL,1000mL CARBOPLATIN,10mg/mL,1000mL CETUXIMAB,5mg/mL,250m - 500mL CISPLATIN,1mg/mL,500mL - 1000mL CYCLOPHOSPHAMIDE,20mg/mL,500mL CYTARABINE,100mg/mL or 20mg/mL,250mL DARATUMUMAB,20mg/mL,100mL - 250mL DOCETAXEL,20mg/mL,250mL - 500mL DOXORUBICIN,2mg/mL,1000mL EPIRUBICIN,2mg/mL,1000mL ETOPOSIDE,20mg/mL,500mL FLUCLOXACILLIN,,3000mL FLUOROURACIL,50mg/mL or 25mg /mL,250-500mL INFLIXIMAB,10mg/mL,500mL - 1000mL IRINOTECAN,20mg/mL,1000mL NIVOLUMAB,10mg/mL,250mL OXALIPLATIN,5mg/mL,500mL-1000mL PACLITAXEL,6mg/mL,1000mL PEMBROLIZUMAB,25mg/mL,100mL - 250mL PEMETREXED,25mg/mL,100mL - 250mL PIPERACILLIN & TAZOBACTAM,,3000mL RITUXIMAB,10mg/mL,500mL TOCILIZUMAB,20mg/mL,250mL TRASTUZUMAB EMTANSINE,20mg/mL,100mL - 250mL VEDOLIZUMAB,60mg/mL,250mL VITLIPID N INFANT,N/A,250mL Please inform us via the contact information above if you are able to provide these products.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-03d4f5
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/016383-2023
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Planning Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£42,317,736 £10M-£100M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
9 Jun 20232 years ago
Submission Deadline
Not specified
Future Notice Date
1 Jan 2025Expired
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Planned
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
VELINDRE NHS TRUST, NHS WALES SHARED SERVICES PARTNERSHIP — PROCUREMENT SERVICES (ON BEHALF OF ALL WALES LHB'S AND TRUSTS)
Contact Name
Not specified
Contact Email
theo.davies@wales.nhs.uk
Contact Phone
+44 2920903883

Buyer Location

Locality
CARDIFF
Postcode
CF14 3UB
Post Town
Cardiff
Country
Wales
Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL5 South East Wales
Small Region (ITL 3)
TLL52 Cardiff and Vale of Glamorgan
Delivery Location
TLL Wales
Local Authority
Cardiff
Electoral Ward
Gabalfa
Westminster Constituency
Cardiff North

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-03d4f5-2023-06-09T10:24:50+01:00",
    "date": "2023-06-09T10:24:50+01:00",
    "ocid": "ocds-h6vhtk-03d4f5",
    "initiationType": "tender",
    "tender": {
        "id": "ocds-h6vhtk-03d4f5",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Licensed Bulk Medicines",
        "status": "planned",
        "classification": {
            "scheme": "CPV",
            "id": "33600000",
            "description": "Pharmaceutical products"
        },
        "mainProcurementCategory": "goods",
        "description": "We are interested in buying the following list of products, in licensed bulk containers of up to the sizes noted below, to be available within a 5 year timeframe. We consider the availability in licensed bulk presentation to be a significant market advantage and are willing to consider entering contracts for supply with suppliers who can meet this presentation requirement for these products. Estimated value in the Wales market of this list is PS42,317,736.61 p/a at current prices. The list is not exhaustive, and we are willing to consider other generic and biosimilar products if licensed bulk presentation can be offered. Drug,Strength,Proposed Vial Size ARSENIC TRIOXIDE,1mg/mL, AZACITIDINE,25mg/mL,500mL BEVACIZUMAB,25mg/mL,100mL - 250mL BORTEZOMIB,2.5mg/mL,50mL CALCIUM FOLINATE,10mg/mL,1000mL CARBOPLATIN,10mg/mL,1000mL CETUXIMAB,5mg/mL,250m - 500mL CISPLATIN,1mg/mL,500mL - 1000mL CYCLOPHOSPHAMIDE,20mg/mL,500mL CYTARABINE,100mg/mL or 20mg/mL,250mL DARATUMUMAB,20mg/mL,100mL - 250mL DOCETAXEL,20mg/mL,250mL - 500mL DOXORUBICIN,2mg/mL,1000mL EPIRUBICIN,2mg/mL,1000mL ETOPOSIDE,20mg/mL,500mL FLUCLOXACILLIN,,3000mL FLUOROURACIL,50mg/mL or 25mg /mL,250-500mL INFLIXIMAB,10mg/mL,500mL - 1000mL IRINOTECAN,20mg/mL,1000mL NIVOLUMAB,10mg/mL,250mL OXALIPLATIN,5mg/mL,500mL-1000mL PACLITAXEL,6mg/mL,1000mL PEMBROLIZUMAB,25mg/mL,100mL - 250mL PEMETREXED,25mg/mL,100mL - 250mL PIPERACILLIN & TAZOBACTAM,,3000mL RITUXIMAB,10mg/mL,500mL TOCILIZUMAB,20mg/mL,250mL TRASTUZUMAB EMTANSINE,20mg/mL,100mL - 250mL VEDOLIZUMAB,60mg/mL,250mL VITLIPID N INFANT,N/A,250mL Please inform us via the contact information above if you are able to provide these products.",
        "value": {
            "amount": 42317736.61,
            "currency": "GBP"
        },
        "lots": [
            {
                "id": "1",
                "description": "We are interested in buying the following list of products, in licensed bulk containers of up to the sizes noted below, to be available within a 5 year timeframe. We consider the availability in licensed bulk presentation to be a significant market advantage and are willing to consider entering contracts for supply with suppliers who can meet this presentation requirement for these products. Estimated value in the Wales market of this list is PS42,317,736.61 p/a at current prices. The list is not exhaustive, and we are willing to consider other generic and biosimilar products if licensed bulk presentation can be offered. Drug,Strength,Proposed Vial Size ARSENIC TRIOXIDE,1mg/mL, AZACITIDINE,25mg/mL,500mL BEVACIZUMAB,25mg/mL,100mL - 250mL BORTEZOMIB,2.5mg/mL,50mL CALCIUM FOLINATE,10mg/mL,1000mL CARBOPLATIN,10mg/mL,1000mL CETUXIMAB,5mg/mL,250m - 500mL CISPLATIN,1mg/mL,500mL - 1000mL CYCLOPHOSPHAMIDE,20mg/mL,500mL CYTARABINE,100mg/mL or 20mg/mL,250mL DARATUMUMAB,20mg/mL,100mL - 250mL DOCETAXEL,20mg/mL,250mL - 500mL DOXORUBICIN,2mg/mL,1000mL EPIRUBICIN,2mg/mL,1000mL ETOPOSIDE,20mg/mL,500mL FLUCLOXACILLIN,,3000mL FLUOROURACIL,50mg/mL or 25mg /mL,250-500mL INFLIXIMAB,10mg/mL,500mL - 1000mL IRINOTECAN,20mg/mL,1000mL NIVOLUMAB,10mg/mL,250mL OXALIPLATIN,5mg/mL,500mL-1000mL PACLITAXEL,6mg/mL,1000mL PEMBROLIZUMAB,25mg/mL,100mL - 250mL PEMETREXED,25mg/mL,100mL - 250mL PIPERACILLIN & TAZOBACTAM,,3000mL RITUXIMAB,10mg/mL,500mL TOCILIZUMAB,20mg/mL,250mL TRASTUZUMAB EMTANSINE,20mg/mL,100mL - 250mL VEDOLIZUMAB,60mg/mL,250mL VITLIPID N INFANT,N/A,250mL Please inform us via the contact information above if you are able to provide these products.",
                "status": "planned"
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33600000",
                        "description": "Pharmaceutical products"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKL"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "communication": {
            "futureNoticeDate": "2025-01-01T00:00:00Z"
        },
        "coveredBy": [
            "GPA"
        ]
    },
    "parties": [
        {
            "id": "GB-FTS-1383",
            "name": "Velindre NHS Trust, NHS Wales Shared Services Partnership -- Procurement Services (on behalf of All Wales LHB's and Trusts)",
            "identifier": {
                "legalName": "Velindre NHS Trust, NHS Wales Shared Services Partnership -- Procurement Services (on behalf of All Wales LHB's and Trusts)"
            },
            "address": {
                "streetAddress": "Procurement Services, 4th Floor, Companies House, Crown Way",
                "locality": "Cardiff",
                "region": "UKL",
                "postalCode": "CF14 3UB",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "telephone": "+44 2920903883",
                "email": "Theo.davies@wales.nhs.uk"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody"
            ],
            "details": {
                "url": "https://etenderwales.bravosolution.co.uk/",
                "buyerProfile": "https://nwssp.nhs.wales/ourservices/procurement-services/",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-1383",
        "name": "Velindre NHS Trust, NHS Wales Shared Services Partnership -- Procurement Services (on behalf of All Wales LHB's and Trusts)"
    },
    "language": "en"
}